Referencias
Artículos de referencia
1. Centers for Disease Control and Prevention. Melioidosis. January 2012 [internet publication].Texto completo
2. Nierman WC, DeShazer D, Kim HS, et al. Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci USA. 2004;101:14246-14251.Texto completo Resumen
3. Srinivasan A, Kraus CN, DeShazer D, et al. Glanders in a military research microbiologist. N Engl J Med. 2001;345:256-258.Texto completo Resumen
4. Dance DAB. Melioidosis and glanders as possible biological weapons. In: Fong I, Alibek K, eds. Bioterrorism and infectious agents: a new dilemma for the 21st century. New York, NY: Springer; 2005:99-145.
5. Federal Select Agent Program. Select agents and toxins list. 2017 [internet publication].Texto completo
6. Punyagupta S. Review of 686 cases and presentation of a new clinical classification. In: Punyagupta S, Sirisanthana T, Stapatayavong B, eds. Melioidosis. Bangkok: Bangkok Medical Publisher; 1989:217-229.
7. Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis. 2010;4:e900.Texto completo Resumen
8. Currie BJ. Melioidosis: evolving concepts in epidemiology, pathogenesis and treatment. Semin Respir Crit Care Med. 2015;36:111-125.Texto completo Resumen
9. Gibney KB, Cheng AC, Currie BJ. Cutaneous melioidosis in the tropical top end of Australia: a prospective study and review of the literature. Clin Infect Dis. 2008;47:603-609.Texto completo Resumen
10. McLeod C, Morris PS, Bauert PA, et al. Clinical presentation and medical management of melioidosis in children: a 24-year prospective study in the Northern Territory of Australia and review of the literature. Clin Infect Dis. 2015;60:21-26.Texto completo Resumen
11. Pagnarith Y, Kumar V, Thaipadungpanit J, et al. Emergence of pediatric melioidosis in Siem Reap, Cambodia. Am J Trop Med Hyg. 2010;82:1106-1112.Texto completo Resumen
12. Dance DA, Davis TM, Wattanagoon Y, et al. Acute suppurative parotitis caused by Pseudomonas pseudomallei in children. J Infect Dis. 1989;159:654-660. Resumen
13. Morse LP, Smith J, Mehta J, et al. Osteomyelitis and septic arthritis from infection with Burkholderia pseudomallei: a 20-year prospective melioidosis study from northern Australia. J Orthop. 2013;10:86-91.Texto completo Resumen
14. Garg R, Shaw T, Bhat SN, et al. Melioidosis: the great mimicker presenting as spondylodiscitis. BMJ Case Rep. 2018 Feb 8;2018. pii: bcr-2017-223223. Resumen
15. Prasad GL. Cranial Melioidosis Presenting as Osteomyelitis and/or Extra-Axial Abscess: Literature Review. World Neurosurg. 2020 Feb;134:67-75.Texto completo Resumen
16. Prabhat V, Gantaguru A, Behera S, et al. Spinal Epidural Abscess in Melioidosis: A Rare Case Report from Eastern India. Cureus. 2019 Mar 6;11(3):e4187.Texto completo Resumen
17. Koszyca B, Currie BJ, Blumbergs PC. The neuropathology of melioidosis: two cases and a review of the literature. Clin Neuropathol. 2004;23:195-203. Resumen
18. Currie BJ, Fisher DA, Howard DM, et al. Neurological melioidosis. Acta Trop. 2000;74:145-151. Resumen
19. Wongwandee M, Linasmita P. Central nervous system melioidosis: A systematic review of individual participant data of case reports and case series. PLoS Negl Trop Dis. 2019 Apr;13(4):e0007320.Texto completo Resumen
20. Chadwick DR, Ang B, Sitoh YY, et al. Cerebral melioidosis in Singapore: a review of five cases. Trans R Soc Trop Med Hyg. 2002;96:72-76. Resumen
21. Bodilsen J, Vammen S, Fuursted K, et al. Mycotic aneurysm caused by Burkholderia pseudomallei in a previously healthy returning traveller. BMJ Case Rep. 2014;2014.Texto completo Abstract
22. Chakravorty A, Heath CH. Melioidosis: An updated review. Aust J Gen Pract. 2019 May;48(5):327-332.Full text Abstract
23. Birnie E, Virk HS, Savelkoel J, et al. Global burden of melioidosis in 2015: a systematic review and data synthesis. Lancet Infect Dis. 2019 Aug;19(8):892-902.Full text Abstract
24. Currie BJ, Dance DA, Cheng AC. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans R Soc Trop Med Hyg. 2008;102(suppl 1):S1-S4. Abstract
25. Limmathurotsakul D, Golding N, Dance DA, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol. 2016;1:15008. Abstract
26. Saïdani N, Griffiths K, Million M, et al. Melioidosis as a travel-associated infection: case report and review of the literature. Travel Med Infect Dis. 2015;13:367-381. Abstract
27. Donahue MA, Newcomb G, Spinella S, et al. CNS Melioidosis in a Traveler Returning from Cabo, Mexico. Open Forum Infect Dis. 2019 Feb;6(2):ofz005.Full text Abstract
28. Yuan Y, Yao Z, Xiao E, et al. The first imported case of melioidosis in a patient in central China. Emerg Microbes Infect. 2019;8(1):1223-1228.Full text Abstract
29. Alwarthan SM, Aldajani AA, Al Zahrani IM, et al. Melioidosis: Can Tropical Infections Present in Nonendemic Areas? A Case Report and Review of the Literature. Saudi J Med Med Sci. 2018 May-Aug;6(2):108-111.Full text Abstract
30. Birnie E, Savelkoel J, Reubsaet F, et al. Melioidosis in travelers: An analysis of Dutch melioidosis registry data 1985-2018. Travel Med Infect Dis. 2019 Jul 29;:101461.Full text Abstract
31. Centers for Disease Control and Prevention. Statement on melioidosis cases. August 2021 [internet publication].Full text
32. Petras JK, Elrod MG, Ty M, et al. Notes from the field: Burkholderia pseudomallei detected in a raccoon carcass linked to a multistate aromatherapy-associated melioidosis outbreak - Texas, 2022. MMWR Morb Mortal Wkly Rep. 2022 Dec 16;71(50):1597-8.Full text Abstract
33. Centers for Disease Control and Prevention. Health alert network: melioidosis locally endemic in areas of the Mississippi Gulf Coast after Burkholderia pseudomallei isolated in soil and water and linked to two cases - Mississippi, 2020 and 2022. Jul 2022 [internet publication].Full text
34. Suputtamongkol Y, Hall AJ, Dance DA, et al. The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int J Epidemiol. 1994;23:1082-1090. Abstract
35. Centers for Disease Control and Prevention. Glanders. October 2017 [internet publication].Full text
36. Podin Y, Sarovich DS, Price EP, et al. Burkholderia pseudomallei isolates from Sarawak, Malaysian Borneo, are predominantly susceptible to aminoglycosides and macrolides. Antimicrob Agents Chemother. 2014;58:162-166.Full text Abstract
37. Currie BJ, Jacups SP. Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis. 2003;9:1538-1542.Full text Abstract
38. Cheng AC, Jacups SP, Gal D, et al. Extreme weather events and environmental contamination are associated with case-clusters of melioidosis in the Northern Territory of Australia. Int J Epidemiol. 2006;35:323-329.Full text Abstract
39. Limmathurotsakul D, Wongsuvan G, Aanensen D, et al. Melioidosis caused by Burkholderia pseudomallei in drinking water, Thailand, 2012. Emerg Infect Dis. 2014;20:265-268.Full text Abstract
40. Goshorn RK. Recrudescent pulmonary melioidosis. A case report involving the so-called 'Vietnamese time bomb'. Indiana Med. 1987;80:247-249. Abstract
41. Van Zandt KE, Greer MT, Gelhaus HC. Glanders: an overview of infection in humans. Orphanet J Rare Dis. 2013;8:131.Full text Abstract
42. Chow TK, Eu LC, Chin KF, et al. Incidental splenic granuloma due to Burkholderia pseudomallei: a case of asymptomatic latent melioidosis? Am J Trop Med Hyg. 2016;94:522-524. Abstract
43. Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med. 2012;367:1035-1044. Abstract
44. Lo TJ, Ang LW, James L, et al. Melioidosis in a tropical city state, Singapore. Emerg Infect Dis. 2009;15:1645-1647.Full text Abstract
45. Limmathurotsakul D, Kanoksil M, Wuthiekanun V, et al. Activities of daily living associated with acquisition of melioidosis in northeast Thailand: a matched case-control study. PLoS Negl Trop Dis. 2013;7:e2072.Full text Abstract
46. Ko WC, Cheung BM, Tang HJ, et al. Melioidosis outbreak after typhoon, southern Taiwan. Emerg Infect Dis. 2007;13:896-898.Full text Abstract
47. Currie BJ, Price EP, Mayo M, et al. Use of whole-genome sequencing to link Burkholderia pseudomallei from air sampling to mediastinal melioidosis, Australia. Emerg Infect Dis. 2015;21:2052-2054.Full text Abstract
48. Amadasi S, Dal Zoppo S, Bonomini A, et al. A case of melioidosis probably acquired by inhalation of dusts during a helicopter flight in a healthy traveler returning from Singapore. J Travel Med. 2015;22:57-60.Full text Abstract
49. Guendel I, Ekpo LL, Hinkle MK, et al. Melioidosis after Hurricanes Irma and Maria, St. Thomas/St. John District, US Virgin Islands, October 2017. Emerg Infect Dis. 2019 Oct;25(10):1952-1955.Full text Abstract
50. Suputtamongkol Y, Chaowagul W, Chetchotisakd P, et al. Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis. 1999;29:408-413.Full text Abstract
51. Limmathurotsakul D, Chaowagul W, Chierakul W, et al. Risk factors for recurrent melioidosis in northeast Thailand. Clin Infect Dis. 2006;43:979-986.Full text Abstract
52. Commons RJ, Grivas R, Currie BJ. Melioidosis in a patient on monoclonal antibody therapy for psoriatic arthritis. Intern Med J. 2014;44:1245-1246. Abstract
53. Fong SM, Wong KJ, Fukushima M, et al. Thalassemia major is a major risk factor for pediatric melioidosis in Kota Kinabalu, Sabah, Malaysia. Clin Infect Dis. 2015;60:1802-1807.Full text Abstract
54. Geake JB, Reid DW, Currie BJ, et al. An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis. BMC Pulm Med. 2015;15:116.Full text Abstract
55. Johnson MM, Ainslie KM. Vaccines for the prevention of melioidosis and glanders. Curr Trop Med Rep. 2017 Sep;4(3):136-145. Abstract
56. Peacock SJ, Schweizer HP, Dance DA, et al. Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg Infect Dis. 2008;14:e2.Full text Abstract
57. Lipsitz R, Garges S, Aurigemma R, et al. Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei infection, 2010. Emerg Infect Dis. 2012;18:e2.Full text Abstract
58. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev. 2005;18:383-416.Full text Abstract
59. Sarovich DS, Garin B, De Smet B, et al. Phylogenomic analysis reveals an Asian origin for African burkholderia pseudomallei and further supports melioidosis endemicity in Africa. mSphere. 2016;1:e00089-15.Full text Abstract
60. Dance DA. Editorial commentary: melioidosis in Puerto Rico: the iceberg slowly emerges. Clin Infect Dis. 2015;60:251-253.Full text Abstract
61. Dance DA. Melioidosis: the tip of the iceberg? Clin Microbiol Rev. 1991;4:52-60.Full text Abstract
62. Sapian M, Khair MT, How SH, et al. Outbreak of melioidosis and leptospirosis co-infection following a rescue operation. Med J Malaysia. 2012;67:293-297.Full text Abstract
63. Currie BJ, Fisher DA, Howard DM, et al. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis. 2000;31:981-986.Full text Abstract
64. Meumann EM, Cheng AC, Ward L, et al. Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clin Infect Dis. 2012;54:362-369.Full text Abstract
65. Stephens DP, Thomas JH, Ward LM, et al. Melioidosis causing critical illness: a review of 24 years experience from the Royal Darwin Hospital ICU. Crit Care Med. 2016;44:1500-1505. Abstract
66. Wuthiekanun V, Suputtamongkol Y, Simpson AJ, et al. Value of throat swab in diagnosis of melioidosis. J Clin Microbiol. 2001;39:3801-3802.Full text Abstract
67. Wuthiekanun V, Dance DA, Wattanagoon Y, et al. The use of selective media for the isolation of Pseudomonas pseudomallei in clinical practice. J Med Microbiol. 1990;33:121-126. Abstract
68. Peacock SJ, Chieng G, Cheng AC, et al. Comparison of Ashdown's medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei. J Clin Microbiol. 2005;43:5359-5361.Full text Abstract
69. Limmathurotsakul D, Wuthiekanun V, Chierakul W, et al. Role and significance of quantitative urine cultures in diagnosis of melioidosis. J Clin Microbiol. 2005;43:2274-2276.Full text Abstract
70. Hoffmaster AR, AuCoin D, Baccam P, et al. Melioidosis diagnostic workshop, 2013. Emerg Infect Dis. 2015;21:e141045.Full text Abstract
71. Wibulpolprasert B, Dhiensiri T. Visceral organ abscesses in melioidosis: sonographic findings. J Clin Ultrasound. 1999;27:29-34. Abstract
72. Lim KS, Chong VH. Radiological manifestations of melioidosis. Clin Radiol. 2010;65:66-72. Abstract
73. Dhiensiri T, Puapairoj S, Susaengrat W. Pulmonary melioidosis: clinical-radiologic correlation in 183 cases in northeastern Thailand. Radiology. 1988;166:711-715. Abstract
74. Wuthiekanun V, Chierakul W, Langa S, et al. Development of antibodies to Burkholderia pseudomallei during childhood in melioidosis-endemic northeast Thailand. Am J Trop Med Hyg. 2006;74:1074-1075.Full text Abstract
75. Kaestli M, Richardson LJ, Colman RE, et al. Comparison of TaqMan PCR assays for detection of the melioidosis agent Burkholderia pseudomallei in clinical specimens. J Clin Microbiol. 2012;50:2059-2062.Full text Abstract
76. Robertson G, Sorenson A, Govan B, et al. Rapid diagnostics for melioidosis: a comparative study of a novel lateral flow antigen detection assay. J Med Microbiol. 2015;64:845-848. Abstract
77. Houghton RL, Reed DE, Hubbard MA, et al. Development of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis. PLoS Negl Trop Dis. 2014;8:e2727.Full text Abstract
78. Rizzi MC, Rattanavong S, Bouthasavong L, et al. Evaluation of the Active Melioidosis Detect™ test as a point-of-care tool for the early diagnosis of melioidosis: a comparison with culture in Laos. Trans R Soc Trop Med Hyg. 2019 Dec 1;113(12):757-763.Full text Abstract
79. Chaowagul W, White NJ, Dance DA, et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis. 1989;159:890-899. Abstract
80. St John JA, Ekberg JA, Dando SJ, et al. Burkholderia pseudomallei penetrates the brain via destruction of the olfactory and trigeminal nerves: implications for the pathogenesis of neurological melioidosis. MBio. 2014;5:e00025.Full text Abstract
81. Morse LP, Moller CC, Harvey E, et al. Prostatic abscess due to Burkholderia pseudomallei: 81 cases from a 19-year prospective melioidosis study. J Urol. 2009;182:542-547. Abstract
82. Cheng AC, Currie BJ, Dance DA, et al. Clinical definitions of melioidosis. Am J Trop Med Hyg. 2013;88:411-413.Full text Abstract
83. Centers for Disease Control and Prevention. Glanders: healthcare response activities. Oct 2017 [internet publication].Full text
84. Pitman MC, Luck T, Marshall CS, et al. Intravenous therapy duration and outcomes in melioidosis: a new treatment paradigm. PloS Negl Trop Dis. 2015;9:e0003586.Full text Abstract
85. Dance D. Treatment and prophylaxis of melioidosis. Int J Antimicrob Agents. 2014;43:310-318.Full text Abstract
86. Chierakul W, Anunnatsiri S, Short JM, et al. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. Clin Infect Dis. 2005;41:1105-1113.Full text Abstract
87. Dance DA, Davong V, Soeng S, et al. Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei. Int J Antimicrob Agents. 2014;44:368-369.Full text Abstract
88. Chetchotisakd P, Chierakul W, Chaowagul W, et al. Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet. 2014;383:807-814.Full text Abstract
89. Cheng AC, McBryde ES, Wuthiekanun V, et al. Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis. Antimicrob Agents Chemother. 2009;53:4193-4199.Full text Abstract
90. Sullivan RP, Ward L, Currie BJ. Oral eradication therapy for melioidosis: Important but not without risks. Int J Infect Dis. 2019 Mar;80:111-114.Full text Abstract
91. Cheng AC, Chierakul W, Chaowagul W, et al. Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis. Am J Trop Med Hyg. 2008;78:208-209.Full text Abstract
92. Cheng AC, Limmathurotsakul D, Chierakul W, et al. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis. 2007;45:308-314.Full text Abstract
93. Cheng AC, Fisher DA, Anstey NM, et al. Outcomes of patients with melioidosis treated with meropenem. Antimicrob Agents Chemother. 2004;48:1763-1765.Full text Abstract
94. Tapia D, Sanchez-Villamil JI, Torres AG. Emerging role of biologics for the treatment of melioidosis and glanders. Expert Opin Biol Ther. 2019 Dec;19(12):1319-1332.Full text Abstract
95. Shearer JD, Saylor ML, Butler CM, et al. GC-072: A Novel Therapeutic Candidate for Oral Treatment of Melioidosis and Infections Caused by Select Biothreat Pathogens. Antimicrob Agents Chemother. 2019 Sep 23;:.Full text Abstract
Use of this content is subject to our disclaimer